|
Indomethacin
|
Cimetidine
|
|
Phenylbutazone
|
Stimulant laxatives
|
|
Concomitant use of 2 or more NSAIDs
|
Long-acting sulfonylureas
|
|
Anticholinergic antidepressants
|
Methocarbamol, baclofen, tetrazepam
|
|
Antipsychotic drugs
|
Cerebral vasodilators (dihydroergocristine, ginkgo-biloba, pentoxifylline, ...)
|
|
Anticholinergic hypnotic drugs
|
Meprobamate
|
|
Anticholinergic antihistamines
|
Gastrointestinal antispasmodic drugs with anticholinergic properties
|
|
Anticholinergic muscle relaxants and antispasmodic drugs
|
Antiemetics, cough suppressants, nasal decongestants, or antidrowsiness drugs with anticholinergic properties
|
|
Concomitant use of drugs with anticholinergic properties
|
Dipyridamole
|
|
Long-acting benzodiazepines (half-life ≥ 20 h)
|
Nitrofurantoin
|
|
Centrally acting antihypertensives
|
Concomitant use of 2 or more psychotropic drugs from the same therapeutic class
|
|
Short-acting calcium-channel blockers
|
Concomitant use of anticholinesterase drugs and drugs with anticholinergic properties
|
|
Reserpine
|
Barbiturates (except phenobarbital)
|
|
Disopyramide
|
Doxazosin
|
|
Ticlopidine
| |
